The future of vaccine research is here and waiting for you! Join Care Access in the development of a new vaccine that may prevent blood infections from UTIs caused by E. coli.
E. coli is the most common cause of urinary tract infections (UTIs).
According to the National Institutes of Health (NIH), UTIs in the elderly often go undetected.
E. coli is a common bacteria that most carry in the digestive tract but may be harmful when it enters the bloodstream.
The Janssen Embrace research study is evaluating an investigational vaccine for blood infections caused by E. coli, the bacteria that causes most UTIs.
“People have to step up and be part of the solution. It’s nothing to be afraid of.”
“I wholeheartedly hope other people will step up and do it, so they have enough people to fully carry this through.”
“I think that people should try to help other islanders by getting this study going, and I think you should do it.”
“We need people to participate in studies to be able to get these things out there and get them approved.”
Eligible participants may: